Namandjé N. Bumpus Principal Deputy Commissioner at U.S. Food And Drug Administration (fda) | Official website
Namandjé N. Bumpus Principal Deputy Commissioner at U.S. Food And Drug Administration (fda) | Official website
This is a 25% decrease from the number of companies inspected in the previous quarter, when four companies received four inspections.
Most of the companies inspected at the time were involved in the Biologics sector. The second most common type of company inspected worked in the Drugs sector.
All of the companies were in line with FDA regulations, and don't need to adjust their managing operations or regulatory/administrative actions.
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
According to its website, the FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality.
| Company Name | Area of Business | Inspection Date | Result |
|---|---|---|---|
| CSL Plasma, Inc. | Biologics | 02/13/2025 | No Action Indicated (NAI) |
| Department of Veterans Affairs Chalmers P Wylie Ambulatory Center | Biologics | 01/23/2025 | No Action Indicated (NAI) |
| West-Ward Columbus, Inc. | Drugs | 01/17/2025 | No Action Indicated (NAI) |
Alerts Sign-up